Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats
- PMID: 9561835
- DOI: 10.1080/02713689808951224
Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats
Abstract
Purpose: Experimental autoimmune uveoretinitis (EAU), an established model for human endogenous (autoimmune) posterior uveitis, is a CD4+ T cell-mediated disease inducible in Lewis rats by intradermal inoculation with retinal antigens. Immunohistochemical studies have previously documented the lymphocyte profiles during various stages of the disease process. The purpose of the present study was to investigate the role of macrophages in EAU.
Methods: EAU was induced in Lewis rats, and the effect of macrophage depletion, using the drug dichlorodimethylene diphosphonate (Cl2MDP) encapsulated in liposomes and administered intravenously, was assessed based on the clinical and histological profile of the disease.
Results: The results have shown that in control animals macrophages occur early, feature prominently throughout the course of the disease and display considerable heterogeneity: marrow-derived ED1+ cells and ED3+ cells are the major infiltrating cells, with many cells also expressing ED7 and ED8. In contrast, few cells expressed the ED2 antigen during EAU, even though ED2+ "resident" macrophages occur in the normal choroid. Macrophage depletion, using intravenously injected dichloromethylene diphosphonate (Cl2MDP) enclosed in liposomes, caused a delay in the onset and a reduction in the severity of EAU when administered during the "effector" stage of the disease, i.e. 9-11 days after inoculation with retinal antigen. The delay in disease onset was greater when liposomes were mannosylated and was accompanied by a reduction in the overall inflammatory cell infiltrate into the eye and reduced tissue damage. In addition, there was a reduction in the level of expression of MHC Class II antigen and CR3 (ED7) antigen, a marker of macrophage activation, in Cl2MDP-treated animals compared to controls.
Conclusion: These results suggest that blood-borne, activated macrophages are major effectors of tissue damage during EAU.
Similar articles
-
Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2195-210. Invest Ophthalmol Vis Sci. 1996. PMID: 8843906
-
Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU).Ocul Immunol Inflamm. 1997 Dec;5(4):223-33. doi: 10.3109/09273949709085063. Ocul Immunol Inflamm. 1997. PMID: 9455739
-
Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis.Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3034-41. doi: 10.1167/iovs.02-1156. Invest Ophthalmol Vis Sci. 2003. PMID: 12824249
-
[Translational research with experimental autoimmune uveoretinitis (EAU)].Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):137-58; discussion 159. Nippon Ganka Gakkai Zasshi. 2007. PMID: 17402560 Review. Japanese.
-
Experimental autoimmune uveoretinitis in the rat and mouse.Curr Protoc Immunol. 2003 May;Chapter 15:15.6.1-15.6.20. doi: 10.1002/0471142735.im1506s53. Curr Protoc Immunol. 2003. PMID: 18432901 Review.
Cited by
-
S100B Up-Regulates Macrophage Production of IL1β and CCL22 and Influences Severity of Retinal Inflammation.PLoS One. 2015 Jul 23;10(7):e0132688. doi: 10.1371/journal.pone.0132688. eCollection 2015. PLoS One. 2015. PMID: 26204512 Free PMC article.
-
Crystallin β-b2 promotes retinal ganglion cell protection in experimental autoimmune uveoretinitis.Front Cell Neurosci. 2024 Sep 10;18:1379540. doi: 10.3389/fncel.2024.1379540. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39318470 Free PMC article.
-
Parabiosis reveals the correlation between the recruitment of circulating antigen presenting cells to the retina and the induction of spontaneous autoimmune uveoretinitis.J Neuroinflammation. 2022 Dec 9;19(1):295. doi: 10.1186/s12974-022-02660-2. J Neuroinflammation. 2022. PMID: 36494807 Free PMC article.
-
Autoimmune and autoinflammatory mechanisms in uveitis.Semin Immunopathol. 2014 Sep;36(5):581-94. doi: 10.1007/s00281-014-0433-9. Epub 2014 May 24. Semin Immunopathol. 2014. PMID: 24858699 Free PMC article. Review.
-
Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis.Br J Ophthalmol. 2007 Apr;91(4):531-7. doi: 10.1136/bjo.2006.101576. Epub 2006 Oct 11. Br J Ophthalmol. 2007. PMID: 17035279 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials